upper respiratory tract infection
Conditions
Interventions
Patients receive 2.5g herbal extract preparation of kikyo-to, a Japanese herbal medicine, desolved with a cup of hot water.
Patients receive 2.5g placebo (lactose), desolved with a cup of hot water.
Sponsors
Akashi Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients of upper respiratory tract infections with a complaint of sore throat, who visited a general internal medicine department office in the Akashi medical center hospital from December 2017 to June 2018 were registered.
Exclusion criteria
Exclusion criteria: Patients with allergy to kikyo-to and lactose, patients with aldosteronism, patients with myopathy, patients with known hypokalemia, pregnant patients or patients with possibility of pregnancy, breastfeeding patients, patients who take kikyo-to, patients inurgent condition, patients who were unable to participate the study because of dementia, visual impairment and unable to answer, or complete the study form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the difference on sore throat VAS scale between 10 minutes after kikyo-to is taken. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are the proportion of patients with sore throat score more than moderate level between 10 minutes after kikyo-to is taken. | — |
Countries
Japan
Contacts
Public ContactNaoto Ishimaru
Akashi Medical Center Department of General Internal Medicine
Outcome results
None listed